Zobrazeno 1 - 10
of 490
pro vyhledávání: '"graves hyperthyroidism"'
Publikováno v:
Endocrinology and Metabolism, Vol 39, Iss 4, Pp 579-589 (2024)
Background Changes in thyrotropin receptor antibody (TRAb) levels are associated with the clinical outcomes of Graves’ hyperthyroidism. However, the effects of the patterns of TRAb changes on patient prognosis according to the treatment duration of
Externí odkaz:
https://doaj.org/article/f3326d3c6eb1499593c7f48033d5ceff
Publikováno v:
Frontiers in Endocrinology, Vol 15 (2024)
BackgroundRadioactive iodine (RAI) therapy is a widely used treatment for Graves’ Hyperthyroidism (GH). However, various factors can impact the non-remission rate of GH after single RAI therapy. This study aimed to develop an online dynamic nomogra
Externí odkaz:
https://doaj.org/article/d7e6c6bd399440dfa31f1738ecc99bbb
Autor:
Chengpeng Gong, Yajing Zhang, Fei Feng, Mengmeng Hu, Kun Li, Rundong Pi, Hua Shu, Rongmei Tang, Xiaoli Wang, Shilin Tan, Fan Hu, Jia Hu
Publikováno v:
EJNMMI Physics, Vol 11, Iss 1, Pp 1-13 (2024)
Abstract Purpose To investigate the optimal threshold for measuring thyroid volume in patients with Grave's hyperthyroidism (GH) by SPECT/CT. Materials and methods A 53 mL butterfly-shaped hollow container made of two 45-degree transparent elbows was
Externí odkaz:
https://doaj.org/article/34b348d0e7204f6ba8d06a84477587b6
Autor:
Meihua Jin, Ahreum Jang, Chae A Kim, Tae Young Kim, Won Bae Kim, Young Kee Shong, Min Ji Jeon, Won Gu Kim
Publikováno v:
European Thyroid Journal, Vol 12, Iss 2, Pp 1-11 (2023)
Objective: This study evaluated the efficacy of antithyroid drugs (ATDs) and risk factors associated with the recurrence of Graves’ hyperthyroidism using a comprehensive retrospective cohort. Methods: We included 1829 patients newly diagnosed with
Externí odkaz:
https://doaj.org/article/00446fd1eb774bedbd54e4c86145df20
Publikováno v:
European Thyroid Journal, Vol 11, Iss 3, Pp 1-6 (2023)
Purpose: In this prospective multicenter study with patients newly diagnosed with Graves’ hyperthyroidism (GH), we studied the timing and characteristics of adverse drug reactions in patients treated with anti-thyroid drugs (ATD) for up to 48 month
Externí odkaz:
https://doaj.org/article/b7f4dbb3454341d18895efedcb60494d
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Infection and Drug Resistance, Vol Volume 15, Pp 1019-1025 (2022)
Shan Tian,1,* Bin Zhu,1,* Youyou Tian,2 Junyuan Li,1 Cheng Peng1 1Department of Infectious Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, Hubei, People’s Republic of China; 2D
Externí odkaz:
https://doaj.org/article/3df6e4b804f049b59298fcf521ab0f2f
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Clinical Case Reports, Vol 10, Iss 2, Pp n/a-n/a (2022)
Abstract Tachycardia and atrial fibrillation, early symptoms of hyperthyroidism indicate significant hemodynamic variation in cardiovascular system, if left untreated and further deterioration in hemodynamics can result in chronic heart failure and l
Externí odkaz:
https://doaj.org/article/a488424a13034dab96896762930fd7c1
Autor:
Rosario Le Moli, Pasqualino Malandrino, Marco Russo, Fabrizio Lo Giudice, Francesco Frasca, Antonino Belfiore, Riccardo Vigneri
Publikováno v:
Frontiers in Endocrinology, Vol 11 (2020)
Background: A course of anti-thyroid drugs (ATD) is the most common first line treatment for Graves' hyperthyroidism. However, hyperthyroidism relapse is frequent (30–70%). Due to the autoimmune nature of Graves' disease, the immunosuppressive trea
Externí odkaz:
https://doaj.org/article/39f6c36c1a27467f88cbef8f4a9b8cad